These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13515081)

  • 21. Effect of the sulphonylureas on fibrinolysis.
    FEARNLEY GR; CHAKRABARTI R; VINCENT CT
    Lancet; 1960 Sep; 2(7151):622-5. PubMed ID: 13698486
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of 3H-glibenclamide binding to sulfonylurea receptors by oral antidiabetics.
    Geisen K; Hitzel V; Okomonopoulos R; Pünter J; Weyer R; Summ HD
    Arzneimittelforschung; 1985; 35(4):707-12. PubMed ID: 3925960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the hypoglycemizing effect of metahexamide.
    GARATTINI S; JORI A; PALMA V; TESSARI L
    Experientia; 1959 Oct; 15():384-5. PubMed ID: 13826354
    [No Abstract]   [Full Text] [Related]  

  • 24. The current status of sulphonylureas in experimental and clinical diabetes.
    TYLER DB
    J Indian Med Assoc; 1960 Dec; 35():549-51. PubMed ID: 13778866
    [No Abstract]   [Full Text] [Related]  

  • 25. A study of the action of hypoglycemia-producing biguanide and sulfonylurea compounds on oxidative phosphorylation.
    FALCONE AB; MAO RL; SHRAGO E
    J Biol Chem; 1962 Mar; 237():904-9. PubMed ID: 13891416
    [No Abstract]   [Full Text] [Related]  

  • 26. Data on the combined action of insulin and hypoglycaemic sulphonylurea.
    TARDOS L; ERDELY I
    Acta Physiol Acad Sci Hung; 1961; 19():297-303. PubMed ID: 13775313
    [No Abstract]   [Full Text] [Related]  

  • 27. Thyroid function in diabetic patients under long-term sulfonylurea treatment.
    NIKKILA EA; JAKOBSON T; JOKIPII SG; KARLSSON K
    Acta Endocrinol (Copenh); 1960 Apr; 33():623-9. PubMed ID: 14427195
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of hypoglycemizing sulfonylureas on the phosphatase activity of the blood].
    da CRUZ
    C R Seances Soc Biol Fil; 1960; 154():229-31. PubMed ID: 13813101
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of sulfonylureas on the respiratory quotient in diabetic and normal animals.
    CERLETTI P; GREGOLIN C
    Clin Chim Acta; 1959 Jul; 4():579-82. PubMed ID: 13808852
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of long-term use of antidiabetic sulfonylureas on thyroid weight and arteriosclerosis.
    NIKKILA EA; TEIR H
    Ann Med Exp Biol Fenn; 1960; 38():182-5. PubMed ID: 14427203
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of sulfonylureas on fructose utilization in diabetes mellitus].
    BAIER H
    Klin Wochenschr; 1959 Apr; 37(7):399-401. PubMed ID: 13642776
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral hypoglycemic agents past and present other than sulfonylurea compounds.
    GOLDNER MG
    AMA Arch Intern Med; 1958 Nov; 102(5):830-40. PubMed ID: 13582273
    [No Abstract]   [Full Text] [Related]  

  • 34. [Inhibitory action of sulfonylureas on the arginase activity of guinea pig liver homogenates].
    TROPEANO L; DI STEFANO S; BELFIORE F
    Boll Soc Ital Biol Sper; 1960 May; 36():495-8. PubMed ID: 13839478
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.
    PFEIFFER EF; PFEIFFER M; DITSCHUNEIT H; AHN CS
    Ann N Y Acad Sci; 1959 Sep; 82():479-95. PubMed ID: 14432532
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of certain sulphonylurea drugs on pantothenic acid metabolism in the rat.
    MIDDLETON EJ; MCLAUGHLAN JM
    Can J Biochem Physiol; 1961 May; 39():837-42. PubMed ID: 13770374
    [No Abstract]   [Full Text] [Related]  

  • 37. Sulfonylurea and non-sulfonylurea hypoglycemic agents: pharmachological properties and tissue selectivity.
    Nagashima K; Takahashi A; Ikeda H; Hamasaki A; Kuwamura N; Yamada Y; Seino Y
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S75-8. PubMed ID: 15563985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Exclusion of the sulfonylureas from any evident inhibitory action on the aldolase activity of guinea pig liver homogenates].
    TROPEANO L; DI STEFANO S; BELFIORE F
    Boll Soc Ital Biol Sper; 1960 May; 36():498-501. PubMed ID: 13839477
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of sulphonylurea drugs on pantothenic acid metabolism in Tetrahymena pyriformis.
    SHENOY KG; McLAUGHLAN JM
    Can J Biochem Physiol; 1959 Nov; 37():1388-9. PubMed ID: 14445820
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on sulfonylurea derivates. I. Synthesis and hypoglycemic action of sulfonylureas].
    NITTA Y; ANDO N; IKEDA Y; KOIZUMI M; SHIOYA A
    Yakugaku Zasshi; 1962 Feb; 82():191-4. PubMed ID: 14480060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.